| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |